Blogs

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma in adults worldwide. It continues to be a challenge to manage because it’s an aggressive disease with about one in three patients not responding to initial   (Read More)

September is Ovarian Cancer Awareness Month and OHC is joining the Ovarian Cancer Alliance of Greater Cincinnati in its efforts to increase awareness and reduce the incidence of this deadly disease. The cancer experts at OHC believe the more women   (Read More)

There are many things we can do to reduce our risk of developing cancer. Eat a healthy, well-balanced diet. Make exercise a regular part of each day. Avoid tobacco and alcohol and stay current on vaccinations and screenings. There is also important   (Read More)

Multiple myeloma is a type of blood cancer for which there is no cure. In 2020, of all patients newly diagnosed with a blood cancer, 18% are expected to be diagnosed with this type of blood cancer. Depending on the stage, the average survival rate   (Read More)

The cancer experts at OHC are raising the alarm about delayed cancer exams, treatment and screenings. Precautionary measures due to COVID-19 have caused much of the disruption, and doctors worry that extended delays may result in many cancer cases   (Read More)

For years, the standard approaches to treating cancer have been surgery, chemotherapy and radiation. The basic idea has been to isolate cancerous cells in your body and either remove or destroy them. These standard approaches can be very effective in   (Read More)

Henry Picagli never expected to be sharing such a personal story with others, but after a near-death episode and a ground-breaking treatment for his non-Hodgkin’s lymphoma, Henry and his wife Jody are now sharing their story to bring a message of   (Read More)

Today, lung cancer remains the leading cancer cause of death in the U.S. for both men and women. And OHC is helping to change that. Historically, the treatment of lung cancer has been extremely challenging because patients typically do not show   (Read More)

Life as we know it changed in March for cancer patients when they were faced with COVID-19. The fear of exposure, the fear of being at risk because of underlying health conditions, and the fear of missing necessary appointments were all real   (Read More)

More Americans are beating cancer thanks to the dedication of the many heroes behind cancer research. In the U.S., the cancer death rate has steadily declined over the past 26 years. It dropped by an average of 1.5% per year between 2008 and 2017.   (Read More)

Each year in June, the world celebrates cancer survivors. At OHC, we understand that being diagnosed with cancer is a personal experience. How people respond to their diagnosis, treatment and emotions differs from person to person. We’ve learned   (Read More)

Breast cancer remains the second leading cause of cancer death in women (lung cancer remains the first). A form of breast cancer that makes up approximately 25 percent of diagnosed patients is called HER2-positive breast cancer. This type of breast   (Read More)

Lung cancer is the leading cancer killer of both men and women in the U.S. It has one of the lowest five-year survival rates of all cancer types. Lung cancer can be treated more successfully when it is found early. However, it is hard to recognize   (Read More)

Skin cancer is one of the most common cancers in the United States. In fact, 1 in 5 people die from skin cancer in the U.S. every hour. Each year it is estimated that 100,000 people in the U.S. will be diagnosed with invasive melanoma of the skin.   (Read More)

The cancer experts at OHC understand that patients diagnosed with cancer may not always have a complete response to the most currently-approved treatments available. At OHC, a dedicated team of researchers lead a nationally-recognized clinical trials   (Read More)